This information was published on 2026-01-13T00:10:29 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2576134 |
| (220) |
12 Aug 2025
|
| (511) (510) |
Class 42
biological research laboratory services; biomedical research services; conducting early evaluations in the field of new pharmaceuticals; consultancy relating to pharmaceutical research and development; drug development services; genetic engineering; laboratory research and analysis; medical research in the field of oncology; research and development in the field of diagnostic preparations; research and development for others with regard to new products; research and development of new products for others; research and development in the field of pharmaceuticals; research and development of pharmaceutical preparations for treating malignant tumours; research and development of vaccines; research and development services in the field of gene expression systems; research in the development and utilization of nanotechnologies; research and development services in the field of antibodies; research services in the field of proteins, antibodies, microorganisms and cells; scientific research in the field of heterologous protein expression |
| (540) |
|
| (730) |
Biointron Biological Inc.
|
| (750) |
MR Peter WANG ipspeedyau@outlook.com
|
Find out more about publications on the About page.